drugset / Trial / NCT06715085

PRGF-ENDORET® Infiltrations in the Treatment of Low Back Pain.

NCT06715085

Phase 4 Recruiting 48 enrolled Biotechnology Institute IMASD
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this clinical trial is to evaluate the efficacy of PRGF in reducing pain and improving patients' quality of life. Researchers will compare an experimental drug (Plasma Rich in Growth Factors) to a control corticosteroid solution in saline solution.

Timeline

Start
2025-01-23
Primary completion
2026-02-01
Completion
2027-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Betamethasone Other / unclassified Other
Subject Plasma Rich in Growth Factors (PRGF) Unknown Other